These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15137074)
1. Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Yuk IH; Olsen MM; Geyer S; Forestell SP Biotechnol Bioeng; 2004 Jun; 86(6):637-42. PubMed ID: 15137074 [TBL] [Abstract][Full Text] [Related]
2. High-titer adenovirus vector production in 293S cell perfusion culture. Cortin V; Thibault J; Jacob D; Garnier A Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892 [TBL] [Abstract][Full Text] [Related]
3. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Henry O; Dormond E; Perrier M; Kamen A Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452 [TBL] [Abstract][Full Text] [Related]
4. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production. Lee YY; Yap MG; Hu WS; Wong KT Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594 [TBL] [Abstract][Full Text] [Related]
5. Development and optimization of an adenovirus production process. Kamen A; Henry O J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761 [TBL] [Abstract][Full Text] [Related]
6. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates. Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552 [TBL] [Abstract][Full Text] [Related]
7. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells]. Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875 [TBL] [Abstract][Full Text] [Related]
8. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection. Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637 [TBL] [Abstract][Full Text] [Related]
9. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Côté J; Garnier A; Massie B; Kamen A Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373 [TBL] [Abstract][Full Text] [Related]
10. Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements. Gálvez J; Lecina M; Solà C; Cairó JJ; Gòdia F J Biotechnol; 2012 Jan; 157(1):214-22. PubMed ID: 22119332 [TBL] [Abstract][Full Text] [Related]
11. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482 [TBL] [Abstract][Full Text] [Related]
12. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system. Jardin BA; Montes J; Lanthier S; Tran R; Elias C Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119 [TBL] [Abstract][Full Text] [Related]
13. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses. Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964 [TBL] [Abstract][Full Text] [Related]
14. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality. Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors. Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729 [TBL] [Abstract][Full Text] [Related]
16. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253 [TBL] [Abstract][Full Text] [Related]
18. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material. Palmer DJ; Ng P Mol Ther; 2004 Oct; 10(4):792-8. PubMed ID: 15451463 [TBL] [Abstract][Full Text] [Related]